LifeSprout
PrivateLast Round
Series A
Apr 27, 2020
Total Funding Raised
$35.5M
Company Overview
LifeSprout operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series A round in April 2020.
LifeSprout is a biotechnology company that develops synthetic soft tissue substitutes for use in aesthetic and reconstructive medicine to facilitate tissue regeneration and repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LifeSprout Comparables
Compare LifeSprout with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiderwort | 82% | |
| Tiger Biosciences | 79% | |
| MTF Biologics | 77% |
For institutional investors. Book with your work email.
LifeSprout Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 27, 2020 | ||||
| Seed | May 29, 2019 | ||||
| Seed | Mar 21, 2018 |
For institutional investors. Book with your work email.
LifeSprout Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| Emerald Development Managers | Series A |
| Abell Foundation | Series A, Seed |
| TEDCO | Seed |
| Kairos Ventures | Seed |
| AngelMD | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 63% MoM, reaching 1.8K.
- Apr 27, 2020
$29M round led by Redmile Group.
For institutional investors. Book with your work email.
LifeSprout Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LifeSprout's valuation, stock price, and market status.
Is LifeSprout a public or private company?
LifeSprout is a private company.
What is the current stock price of LifeSprout?
LifeSprout is a private company, so its shares have no public market price. Caplight tracks LifeSprout's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LifeSprout worth (valuation)?
Valuation information for LifeSprout is not publicly available.
Can I buy LifeSprout stock?
LifeSprout shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LifeSprout's last funding round?
LifeSprout's most recent funding round was Series A on April 27, 2020.
Who are the main investors in LifeSprout?
Key investors in LifeSprout include Redmile Group, TEDCO, Kairos Ventures.
Will LifeSprout IPO soon?
No public IPO plans have been announced for LifeSprout.
How can I track LifeSprout secondary market activity?
Caplight tracks bids, offers, and trades in LifeSprout's shares on secondary markets.